Investigating the role of chromatin-associated RNA processing in early B-cell development
Active Project Grant Awarded Last action
- Award ID
- F31AI188882
- Recipient
-
The Trustees Of Columbia University In The City Of New York UEI QHF5ZZ114M72
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $345,650
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date 57% complete
- Place of performance
- New York, NY 10032, USA
Award details come from USAspending.gov.
Description
- Abstract
- B-cells are unique among mammalian cells because of their ability to undergo programmed genomic rearrangements. The first of these rearrangements is called VDJ recombination and is primarily responsible for generating the vast diversity of antibodies seen in nature. This is critical for the development of the adaptive immune system, but generating double-stranded DNA breaks is an enormous risk to the cell, therefore VDJ recombination must be tightly regulated. My lab has previously shown that VDJ recombination depends on the RNA exosome's 3' RNA processing activity. After losing the RNA exosome pro-B-cells accumulate non-coding rnas throughout thelocus. My project seeks to build upon these findings by finding the exact mechanism through which the RNA exosome and RNA helicases act during VDJ recombination. I will use novel mouse models to investigate RNA helicases that have been shown to act on chromatin-associated rnas that I hypothesize play a role in VDJ recombination. I will confirm these results in a RAG-inducible in-vitro system to confirm that off-target genomic instability is not causing the defect in VDJ recombination and investigate the transcriptional status of RNA processing deficient pro-B-cells. After these experiments, I will perform experiments to identify the status of the chromatin-associated RNA at theloci and how they affect the frequency and structure of double-strand breaks at recombination signal sequences. Finally, I will attempt to rescue the defect by targeting a DCAS9-rnaseh construct to sites with increased chromatin-associated rnas in helicase or exosome-deficient backgrounds, showing that the helicases and the exosome play an active and direct role in VDJ recombination, independent of their role elsewhere in the genome.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $576 | |
| Amendment | $49,538 | |
| Amendment | $49,538 | |
| Amendment | $564 | |
| Amendment | $564 | |
| Amendment | $48,974 | |
| Amendment | $0 | |
| Amendment | $48,974 | |
| Amendment | $0 | |
| Amendment | $48,974 | |
| Amendment | $48,974 | |
| Original award | $48,974 |
Show all 12
Quick answers
Who received award F31AI188882?
F31AI188882 was awarded to The Trustees Of Columbia University In The City Of New York by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on May 26, 2025.
How much is award F31AI188882 worth?
$345,650 has been obligated on F31AI188882.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award